Literature DB >> 16111467

DNA methylation: its role in lung carcinogenesis and therapeutic implications.

Edgardo S Santos1, Luis E Raez, Teresa DeCesare, Rakesh Singal.   

Abstract

A new era in the treatment of malignant diseases has been observed through the use of biologic agents targeting growth factor receptors, signaling pathways, gene mutations and others. The results have been impressive in some diseases and modest in others. The discovery of new targets has expanded our knowledge of different mechanisms in tumorigenesis. One of these mechanisms has been DNA methylation, which is an important gene transcription regulator. Although the role of methylation in lung carcinogenesis is not well understood, there is an enormous quantity of evolving data suggesting its critical role in lung cancer. In this review, the authors will discuss methylation in lung carcinogenesis and its possible clinical implications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16111467     DOI: 10.1586/14737140.5.4.667

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  1 in total

1.  Deoxyribonucleic acid (DNA) methyltransferase contributes to p16 promoter CpG island methylation in lung adenocarcinoma with smoking.

Authors:  Rongju Sun; Jiahong Liu; Bo Wang; Lingyun Ma; Xiaojiao Quan; Zhixiang Chu; Tanshi Li
Journal:  Int J Clin Exp Med       Date:  2015-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.